A proteomic network approach across the ALSFTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

Publisher: John Wiley & Sons Inc

E-ISSN: 1757-4684|10|1|48-62

ISSN: 1757-4676

Source: EMBO Molecular Medicine, Vol.10, Iss.1, 2018-01, pp. : 48-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract